Androgen receptor-regulated signaling pathways play a key role in the progression of the prostate cancer in which androgen-metabolizing enzymes CYP3A4, CYP3A5, and CYP3A43 are expressed. This evidence concerns the gene CYP3A5 and prostate cancer.